Side hustles are all the rage these days, and they're instrumental in helping millions of Americans boost their savings, pay off debt, and have more money on hand for leisure, large purchases, or everyday bills. But one drawback to having a second income source is that it can ma
What stock will go up the most in 2020? We'd all like to know that one. And it's a question that's a lot easier to ask than to answer. Let's start by looking at the top 10 stocks of 2019 for clues. The No. 1 stock of 2019, Axsome Therapeutics, had a staggering 3,578% return
The higher your credit score, the more borrowing options you'll open up. Having good credit could help you qualify for an affordable mortgage, get approved for a personal loan at a competitive rate, or snag a credit card with awesome perks. It can also make it possible for you t
Spotify (NYSE: SPOT) had said it was prepared to spend up to $500 million in 2019 on acquisitions to boost its podcast ambitions, kicking off the year by buying Gimlet Media, Anchor FM, and Parcast for a total of 358 million euros, which is about $387 million at current exchange
The monthly benefit you receive from Social Security in retirement is based on your earnings during your 35 highest-paid years in the workforce. But you actually have the power to raise that benefit substantially. All you need to do is delay your filing until age 70 to score the
Gilead Sciences (NASDAQ: GILD) has been getting a lot of attention these days for remdesivir, its possible treatment for the coronavirus, which so far has resulted in more than 2,000 deaths. Even though remdesivir could be a plus for the company if approved, there are still too
Zscaler (NASDAQ: ZS) continues to deliver strong performance. During the past quarter, the cloud cybersecurity specialist posted guidance-beating results, and management raised its full-year outlook. But revenue growth is decelerating and losses are increasing as the company ra
Marathon Oil (NYSE: MRO) has become a cash flow machine over the past two years. The oil company has produced free cash flow after funding growth and paying its dividend in each of the last eight quarters. Overall, it has generated $1.3 billion in excess cash during that time f
The past several years have not been very kind to investors in Tanger Factory Outlet Centers (NYSE: SKT). The owner of outdoor outlet malls has seen its shares lose more than two-thirds of their value from the 2016 peak, and now trade at 10-year-lows. Moreover, the sell-off in
You probably already know about the gender gap as it applies to traditional jobs, but you might be surprised to know that it's also an issue with side hustles. The Ascent recently conducted a survey of nearly 500 adults with side hustles and found that the average man earned nea
Younger Americans are often flagged as financially irresponsible, caring little about their lack of savings and more about their social media feeds. But new data from Nationwide reveals that millennials have a number of near-term money-related concerns. Here are their top three
Investors looking for high-growth, high-risk investments in the most cutting-edge areas of biotech should consider the world of gene editing. While there aren't many companies in this market to choose from, the few stocks that are dedicated to developing gene-editing drugs have
Early in 2019, e.l.f. Beauty (NYSE: ELF) responded to the "retail apocalypse" by closing all 22 of its retail stores, laying off about half of its USA workforce in the process. Relying on its online savvy and e-commerce for sales, e.l.f. seems to be running as a profitable enter
The COVID-19 coronavirus. Presidential campaigns. Uncertainty about what the Federal Reserve Board will do with interest rates. All of these factors have weighed on investors' minds as the stock market pulled back this week.
The 2020 presidential race is off and running, and there have been some early surprises in the first couple of contests. After having lagged by considerable margins in most polls leading up to February's Iowa caucuses and New Hampshire primary, Sen. Amy Klobuchar (D-Minn.) made
It's been a few months since Bristol-Myers Squibb (NYSE: BMY) completed its $74 billion purchase of Celgene, but investors still aren't sure if a couple of key assets that spurred the transaction will ever generate sales.
The rules for divvying up your assets are a bit different in retirement than during your working years. The reason? When you still have a paycheck coming in from work, you can afford to take on more risk in your investment portfolio. Once that steady paycheck goes away, you'll w
The Motley Fool
Checked
16 minutes 47 seconds ago
This feed is responsible for generating the rss feed related to the topic Markets